Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EyePoint, Inc.EYPT · Entity 5702 | See Remarks | May 14, 2018 | May 16, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EyePoint, Inc.
Report date May 14, 2018 · Filed May 16, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.95 · Expires 2028-05-14 | Direct | 375,000 |
Reported balance
After 2018-05-14 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-05-14 · Grant · Acquired 375,000 · Balance 375,000 F1: The option to purchase will vest and become exercisable in three equal annual installments beginning May 14, 2019. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.95 · Expires 2028-05-14 | Direct | 65,000 |
Reported balance
After 2018-05-14 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-05-14 · Grant · Acquired 65,000 · Balance 65,000 F2: The option to purchase will vest and become exercisable in full on May 14, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: The option to purchase will vest and become exercisable in three equal annual installments beginning May 14, 2019.
F2: The option to purchase will vest and become exercisable in full on May 14, 2019.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 14, 2018 Filed May 16, 2018 21:25 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantEmployee Stock Option (right to buy) · Derivative | 65,000 | $0.00 Strike: $1.95 | $0.00 |
DisclosureSEC source: 0000899243-18-013140 · doc4.xml · derivative · entry 2 BLUM LEONARD M · CIK 0001222247 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2028-05-14 F2 · derivative.exercise_date: The option to purchase will vest and become exercisable in full on May 14, 2019. Read SEC document |
| May 14, 2018 Filed May 16, 2018 21:25 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantEmployee Stock Option (right to buy) · Derivative | 375,000 | $0.00 Strike: $1.95 | $0.00 |
DisclosureSEC source: 0000899243-18-013140 · doc4.xml · derivative · entry 1 BLUM LEONARD M · CIK 0001222247 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,000 Underlying: Common Stock · 375,000 shares Expires 2028-05-14 F1 · derivative.exercise_date: The option to purchase will vest and become exercisable in three equal annual installments beginning May 14, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.